Metastasis-associated protein 2 (MTA2) is overexpressed in certain malignancies, and plays important roles in tumour metastasis and progression. The present study highlights the function of MTA2 in pancreatic carcinoma through its role as a deacetylator of hypoxia-inducible factor-1 (HIF-1) and a cotranscriptional factor for E-cadherin expression. We found that overexpression of MTA2 promoted, and knockdown of MTA2 inhibited, the invasion and proliferation of pancreatic carcinoma cells both in vitro and in xenograft models in vivo. We also found that MTA2 is transcriptionally upregulated by HIF-1 through a hypoxia response element (HRE) of the MTA2 promoter in response to hypoxia. Reciprocally, MTA2 deacetylates HIF-1 and enhances its stability through interacting with histone deacetylase 1 (HDAC1). Consequently, HIF-1 recruits MTA2 and HDAC1 to the HRE of the E-cadherin promoter, by which E-cadherin transcription is repressed. In agreement with these experimental results, MTA2 is positively associated with HIF-1, but inversely correlated with E-cadherin, in pancreatic carcinoma samples. Moreover, data from The Cancer Genome Atlas on 172 pancreatic carcinomas indicate an association between high expression of MTA2 and short overall survival. Taken together, our study identifies MTA2 as a critical hub and potential therapeutic target to inhibit the progression and metastasis of pancreatic carcinoma.
Introduction
Pancreatic carcinoma is the fourth leading cause of death from cancer [1] . The very poor prognosis is due to a lack of markers for early diagnosis, broad resistance to chemotherapy and radiotherapy, rapid invasion of surrounding structures, and early metastasis. Pancreatic carcinoma has either metastasized to distant sites or advanced locally at the time of diagnosis, with subsequent median survival times of approximately 4.5 and 10.6 months, respectively [2] . Therefore, a better understanding of the mechanisms leading to the metastatic phenotype in pancreatic carcinoma is needed to improve patient outcomes.
E-cadherin, encoded by the CDH1 gene, is a single-span transmembrane glycoprotein that maintains intercellular contacts and cellular polarity in epithelial tissues. Loss of E-cadherin is believed to induce epithelial-mesenchymal transition (EMT), which is associated with tumour invasiveness, metastatic dissemination and poor prognosis in several solid tumours [3] . E-cadherin expression is frequently reduced in pancreatic carcinoma and the reduction of E-cadherin expression correlates with dedifferentiation and metastasis [4, 5] and is an independent predictor of poor outcome [6] . These results indicate that E-cadherin plays an important role in metastasis and progression, but its regulatory mechanism in pancreatic carcinoma needs further investigation.
Because of an aberrant blood supply and unlimited growth of tumour cells, hypoxia is a characteristic feature of the microenvironment of solid tumours [7] . Hypoxia can promote EMT via hypoxia-inducible factor-1α (HIF-1α) in a variety of tumours [8] . HIF-1α
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signal pathways, such as Wnt/β-catenin, Met, and Notch, are involved in HIF-1α-induced EMT under hypoxia. Importantly, upregulation of HIF-1α is associated with angiogenesis, cell migration, and hepatic metastasis, as well as distant recurrence in pancreatic carcinoma patients [10] [11] [12] . HIF-1α induces an EMT phenotype with downregulation of E-cadherin, whereas silencing of HIF-1α reverses the effects of hypoxia on the EMT process and invasion in pancreatic carcinoma cells [13, 14] . However, the precise mechanism by which HIF-1α downregulates E-cadherin expression needs further elucidation.
Metastasis-associated protein (MTA) 2 (MTA2) is a subunit of the nucleosome-remodelling and histone deacetylation (NuRD) complex [15] . MTAs maintain the stability of the NuRD complex, and aid in directing histone deacetylase (HDAC) activity from the associated HDAC proteins to target molecules. MTA2 also deacetylates oestrogen receptor-α and p53, and inhibits their transactivation functions [16, 17] . Specifically, MTA2 is overexpressed in pancreatic carcinoma and is associated with a lower overall survival rate [18] . Moreover, miR-146a can directly inhibit MTA2 expression or indirectly downregulate MTA2 through the inhibition of epidermal growth factor receptor, leading to the suppression of pancreatic carcinoma cell invasion and metastasis [19] . Notably, MTA2 is recruited by TWIST to the proximal promoter regions of E-cadherin, and is involved in TWIST-mediated downregulation of E-cadherin, suggesting an essential role of MTA2 in EMT and metastasis of cancer cells [20] . In addition, expression of MTA1, another member of the MTA family, is induced under hypoxia in breast cancer cell lines [21] . When MTA1 was overexpressed, the transcriptional activity and stability of HIF-1α protein were enhanced, suggesting a positive loop between MTA1 and HIF-1α [22, 23] . Given the similarity between MTA1 and MTA2 in molecular structure and function, the present study investigated whether reciprocal feedback on HIF-1α and MTA2 represses E-cadherin to contribute to metastasis and progression of pancreatic carcinoma.
Materials and methods

Clinical samples
Tumours and matched non-cancerous tissues were obtained from patients undergoing radical pancreatectomy or palliative surgery including I 125 seed implantation as well as choledochojejunostomy and gastroenterostomy according to the National Comprehensive Cancer Network guidelines for pancreatic carcinoma in Union hospital (Wuhan, China). The tissues of palliative surgery patients were obtained by biopsy. The diagnosis of pancreatic carcinoma was confirmed by the original histopathological reports. The excised tissue was embedded in paraffin, or snap-frozen and stored at -80 ∘ C. All of the clinical samples were collected with written informed consent from patients, and permission for the research was obtained from the , and each target band density was normalized to the corresponding internal reference (GAPDH) to obtain the relative density of each band in order to reflect the protein level in data analysis.
For coimmunoprecipitation, cell extracts were incubated with the primary antibody or normal mouse/rabbit IgG overnight at 4 ∘ C, and then with Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) for 2 h at 4 ∘ C. Agarose was collected and washed with lysis buffer. Equal volumes of sample were analysed by western blotting.
Invasion assay
Transwell migration chambers with 8-μm-pore polycarbonate membranes (Corning, Shanghai, China) were precoated with a thin layer of Matrigel Basement Membrane Matrix (BD Biosciences, Shanghai, China). Suspensions of 5 × 10 4 cells in 100 μl of medium were added to the upper chamber. Medium with 30% fetal bovine serum was used as a chemoattractant in the lower chamber. After 24 h, migrated cells on the membrane of the upper chamber were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, and counted under a microscope in nine random fields. Each experiment was performed in triplicate. 
Statistical analysis
All data were analysed with SPSS 13.0 software and presented as the mean ±standard deviation (SD). Differences between groups were assessed with t-tests. The expression of MTA2 in 48 pancreatic carcinoma and paired adjacent non-cancerous tissues was analysed with paired t-tests. The correlations among MTA2, E-cadherin and HIF-1α in pancreatic carcinoma tissues were analysed with the chi-square test. Differences were considered to be significant at p < 0.05, p < 0.01, and p < 0.001.
Supplementary methods
Other methods, including cell culture and reagents, transfection, chromatin immunoprecipitation (ChIP), luciferase reporter assay, quantitative reverse transcription polymerase chain reaction (qRT-PCR), immunohistochemistry (IHC), immunofluorescence (IF), and cell proliferation assay, are provided in supplementary materials and methods. The IHC and IF were carried out as previously described [24] .
Results
MTA2 facilitates invasion and proliferation of pancreatic carcinoma cells
We first assessed MTA2 expression in pancreatic carcinoma tissues. The MTA2 mRNA level was higher in carcinoma tissues than in paired non-cancerous pancreatic tissues ( Figure 1A ). Immunohistochemical results confirmed that MTA2 was upregulated in pancreatic carcinoma tissues as compared with paired adjacent non-cancerous tissues ( Figure 1B ). To validate the association between MTA2 and pancreatic carcinoma progression, a dataset of 172 cases of pancreatic adenocarcinoma from The Cancer Genome Atlas (TCGA) was analysed online by LinkedOmics. The results showed that high expression of MTA2 was associated with shorter overall survival (supplementary material, Table S1 ). Furthermore, mRNA and protein levels of MTA2 were higher in pancreatic carcinoma cell lines (PANC-1, BxPC-3, and SW1990) than in normal pancreatic ductal cells (HPDE) (supplementary material, Figure S1 ). Together, these results indicated that MTA2 functions as a cancer-promoting protein in pancreatic carcinoma.
To understand the role of MTA2, MTA2 expression was manipulated with small interfering RNA (siRNA) or overexpression plasmid in PANC-1 and BxPC-3 cells. After knockdown with MTA2 siRNA (siMTA2) (supplementary material, Figure S2 ), the proliferation and invasion of PANC-1 cells ( Figure 1C ,D) and BxPC-3 cells (supplementary material, Figure S3A ,B) were inhibited. In contrast, MTA2 overexpression increased the proliferation and invasion of PANC-1 and BxPC-3 cells (supplementary material, Figure S4A -C).
To investigate the biological function of MTA2 in vivo, PANC-1 cells transfected with lentivirus containing siMTA2 (LV-siMTA2) or MTA2 overexpression vector (MTA2-OE) and their control (LV-siNC, vector) were implanted into nude mice. Tumours of mice in the LV-siMTA2 group were smaller and lighter than those in the LV-siNC group ( Figure 1E) . Moreover, the number of mice with liver and lung metastases in the LV-siMTA2 group was lower than that in the LV-siNC group ( Figure 1F,G) . In contrast, MTA2-OE mice showed larger and heavier tumours, as well as more liver and lung metastases, than those in the control vector group (supplementary material, Figure S5A -C).
MTA2 represses E-cadherin transcription
MTA2 is physically associated with HDAC1 to form the NuRD complex [25] . Coimmunoprecipitation showed that MTA2 and HDAC1 could recruit each other (supplementary material, Figure S6A ). Given the critical role of E-cadherin in metastasis, we evaluated whether E-cadherin is regulated by the MTA2-HDAC1 complex. Knockdown of MTA2 resulted in upregulation of E-cadherin at both the mRNA level and the protein level (supplementary material, Figure S6B ). Conversely, MTA2 overexpression decreased E-cadherin mRNA and protein levels (supplementary material, Figure S6C ). Moreover, knockdown of HDAC1 increased mRNA and protein expression of E-cadherin (supplementary material, Figure S6D ). To investigate whether the binding of MTA2-HDAC1 represses E-cadherin promoter activity, an E-cadherin promoter luciferase reporter vector was transfected into PANC-1 cells. Luciferase analysis showed that MTA2 overexpression inhibited E-cadherin promoter activity, whereas knockdown of MTA2 and HDAC1 increased this activity (supplementary material, Figure S6E ,F).
Hypoxia induces dysregulation of MTA2/E-cadherin expression in an HIF-1α-mediated manner the level of HIF-1α protein was increased, and this was accompanied by upregulation of MTA2 at both the mRNA level and the protein level (Figure 2A,B) . In contrast, knockdown of HIF-1α reduced MTA2 mRNA and protein levels but increased those of E-cadherin ( Figure 2C ). HIF-1α overexpression increased MTA2 expression (supplementary material, Figure S7 ). These results were verified by IHC, which showed that knockdown of HIF-1α or MTA2 increased E-cadherin expression, whereas overexpression of HIF-1α and Figure S9 ). In agreement with this, HIF-1α levels positively correlated with MTA2 levels, but inversely with E-cadherin levels, in human pancreatic carcinoma samples (supplementary material, Figure S10 ). These results indicate an interaction among HIF-1α, MTA2 and E-cadherin in pancreatic carcinoma.
HIF-1α transcriptionally regulates MTA2 expression
The MTA2 promoter contains seven potential HREs (HREs 1-7 ; Figure 3A) . ChIP with anti-HIF-1α antibody revealed that HIF-1α was bound to the region containing HRE-4 and HRE-5 ( Figure 3B ). To investigate whether HIF-1α activates the MTA2 promoter, luciferase reporter assays were performed in PANC-1 cells transfected with pGL3-promoter vector (pGL3), pGL3-MTA2 promoter vector containing wild-type HRE (WT), mutant HRE-4 (MUT-1), mutant HRE-5 (MUT-2), or co-mutant HRE-4 and HRE-5 (MUT-3) ( Figure 3C ). Both CoCl 2 and HIF-1α overexpression increased MTA2 promoter activity, whereas knockdown of HIF-1α impaired MTA2 promoter activity in cells transfected with WT, MUT-1, and MUT-2, but not in cells transfected with MUT-3 ( Figure 3D,E) . These results suggest that HIF-1α regulates MTA2 at the transcriptional level.
MTA2-HDAC1 enhances deacetylation and stability of HIF-1α
To explore the possibility of crosstalk between MTA2 and HIF-1α, MTA2 was modulated to enable investigation of the alterations in HIF-1α expression. Although there were no distinct effects on mRNA levels, MTA2 overexpression increased, whereas MTA2 knockdown decreased, HIF-1α protein levels ( Figure 4A,B) . To investigate the mechanism, HIF-1α protein levels were measured over time after blocking of further protein synthesis with cycloheximide (CHX) in PANC-1 cells. As compared with transfection with vector, HIF-1α remained stable in PANC-1 cells transfected with MTA2-OE under normoxia ( Figure 4C ). In contrast, depletion of MTA2 impaired HIF-1α stability under hypoxia ( Figure 4D ), indicating that MTA2 regulates HIF-1α expression at the post-transcriptional level by stabilizing HIF-1α protein.
MTA2 is physically associated with HDAC1 to form the NuRD complex [25] , and HDAC1 is considered to be a positive regulator of HIF-1α stability [26] . Therefore, we speculated that HDAC1 is associated with the MTA2-induced stabilization of HIF-1α. First, coimmunoprecipitation verified interactions of HIF-1α with MTA2 and HDAC1 ( Figure 4E ). Moreover, trichostatin A (TSA), an inhibitor of HDACs, suppressed HIF-1α protein which was induced by hypoxia or MTA2 overexpression ( Figure 4F ). Furthermore, we investigated whether MTA2 regulates acetylation of HIF-1α. Acetylation of HIF-1α was reduced during hypoxia, whereas knockdown of MTA2 increased HIF-1α acetylation under hypoxia or normal growth conditions ( Figure 4G ). On the other hand, MTA2 overexpression decreased acetylation of HIF-1α, which was rescued by TSA ( Figure 4H ). These data indicate that the interaction of HIF-1α with the MTA2-HDAC1 complex leads to deacetylation and stabilization of HIF-1α protein.
HIF-1α recruits MTA2-HDAC1 to E-cadherin promoter HREs and inhibits transcription
We investigated whether HIF-1α recruits the MTA2-HDAC1 complex to two putative HREs identified in the E-cadherin promoter ( Figure 5A ). ChIP revealed that HIF-1α was specifically bound to HRE-1 but not to HRE-2 ( Figure 5B ). CoCl 2 decreased the luciferase activity of PANC-1 cells transfected with vector containing wild-type but not mutant HRE, which was rescued by knockdown of HIF-1α. Nevertheless, neither CoCl 2 nor HIF-1α knockdown affected the luciferase activity of PANC-1 cells transfected with vector containing mutant E-cadherin promoter ( Figure 5C ). Similarly, MTA2 and HDAC1 bound to the same HRE, and this binding was reinforced by hypoxia ( Figure 5D ). Furthermore, either MTA2 or HDAC1 knockdown impaired the inhibitory effect of CoCl 2 on E-cadherin promoter activity ( Figure 5E ). Similarly, HIF-1α overexpression decreased the activity of the E-cadherin promoter, which could be rescued by knockdown of both MTA2 and HDAC1 ( Figure 5F ). To further investigate whether E-cadherin might be regulated at the post-translational level by the MTA2-HDAC1 complex, E-cadherin protein levels were evaluated over time after blocking of further protein synthesis with CHX in PANC-1 cells. E-cadherin protein showed a similar degradation rate in PANC-1 cells transfected with siMTA2 as in cells transfected with siRNA negative control (siNC) (supplementary material, Figure S11 ). These results indicated that HIF-1α inhibits E-cadherin transcription via recruitment of the MTA2-HDAC1 complex to the E-cadherin promoter.
MTA2 and HDAC1 are critical for hypoxia-induced reduction of E-cadherin expression
To further validate the role of MTA2 and HDAC1 in hypoxia-induced loss of E-cadherin expression, PANC-1 cells with knockdown of MTA2 or HDAC1 were cultured under hypoxia. After 24 h, E-cadherin expression was reduced. However, knockdown of MTA2 or HDAC1 rescued the inhibitory effect of hypoxia on E-cadherin levels ( Figure 6A,B) . Similarly, HIF-1α overexpression decreased E-cadherin expression, whereas silencing of MTA2 or HDAC1 impaired HIF-1α-induced repression of E-cadherin expression ( Figure 6C ). To investigate the effects of MTA2 on the invasion during hypoxia, which was rescued by HIF-1a overexpression (supplementary material, Figure S12 ). siHIF-1α inhibited the proliferation and invasion of PANC-1 cells during hypoxia, which was rescued by MTA2 overexpression. These functional results further validated the critical role of the HIF-1α-MTA2 pathway in the proliferation and invasion of pancreatic carcinoma cells under conditions of hypoxia. Taken together, the results suggest that MTA2-HDAC1 is critical for HIF-1α-mediated reduction of E-cadherin expression. study, we showed that HIF-1α promotes transcription of MTA2 by binding to HREs in the MTA2 promoter. Conversely, MTA2 deacetylates HIF-1α by recruiting HDAC1, leading to stabilization of HIF-1α. Consequently, HIF-1α recruits the MTA2-HDCA1 complex to an HRE in the E-cadherin promoter, and consequently suppresses its transcription, the loss of which contributes to metastatic dissemination of pancreatic carcinoma. Therefore, we have elucidated an essential function of reciprocal feedback on HIF-1α and MTA2 in EMT and metastasis of pancreatic carcinoma by reducing E-cadherin expression.
Research has demonstrated that MTA2 contributes to more aggressive malignant phenotypes of numerous cancers, including cervical carcinoma, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma [27] . In this study, we showed that MTA2 levels are higher in pancreatic carcinoma tissues than in peritumoural tissues. Furthermore, in vitro and in vivo results showed that MTA2 promotes the invasion and proliferation of pancreatic carcinoma cells. As MTA2 influences proliferation, the experimental results regarding metastasis might be not totally attributable to its effect on invasion and migration. Nevertheless, our data imply that MTA2 contributes, at least partially, to the metastasis of pancreatic carcinoma. Similarly, research from several groups has highlighted that MTA2 facilitates cancer progression. Multivariate analysis showed that a high MTA2 protein level was an independent prognostic factor for lower overall survival of pancreatic carcinoma patients [18] . MTA2 was correlated with tumour invasion and tumour embolus formation in gastric carcinoma, and trapping MTA2 in the cytosol or knockdown of MTA2 inhibited growth and metastasis [28] . MTA2 is an independent prognostic factor for the survival of colorectal carcinoma patients, and high MTA2 expression correlated with poor overall survival [29] . TCGA data of 172 cases of pancreatic carcinoma showed an association between high expression of MTA2 and shorter overall survival. These data indicate a critical role of MTA2 in pancreatic carcinoma progression. In gastric carcinoma, transcription factor specificity protein 1 promotes transcription of MTA2 by directly binding to the MTA2 promoter [30] . However, the mechanism of upregulation of MTA2 in pancreatic carcinoma has not been elucidated fully. Hypoxia causes the stabilization of HIF-1α and transcriptional induction of various genes by binding to HREs in their promoters. Therefore, we wondered whether MTA2 is transcriptionally regulated by HIF-1α during hypoxia, and we demonstrated that hypoxia induced MTA2 expression in an HIF-1α-mediated manner. Although seven HREs were predicted to be present in the MTA2 promoter, ChIP and luciferase reporter assays showed that only HRE-4 and HRE-5 were bound by HIF-1α. Moreover, MTA2 knockdown inhibited the proliferation and invasion of PANC-1 cells, which could be rescued by HIF-1α overexpression during hypoxia. Vice versa, MTA2 overexpression rescued the inhibitory effect of siHIF-1α on the proliferation and invasion of PANC-1 cells during hypoxia. These results indicate that MTA2 is a critical target of HIF-1α that contributes to the progression of pancreatic carcinoma.
HIF-1α is a key transcription factor that is induced and stabilized by hypoxia. Post-translational modifications including hydroxylation, ubiquitination, acetylation, S-nitrosation, and phosphorylation, have been shown to determine the half-life and/or transcriptional activity of HIF-1α [31] . Acetylation of HIF-1α at lysine 532 in the ODD domain by the ARD1 acetyltransferase increased the interaction of von Hippel-Lindau protein with HIF-1α, stimulating its ubiquitylation and proteasomal degradation [32] . HIF-1α can be stabilized by several oncogenes through hypoxia-independent mechanisms. MUC1 enhances HIF-1α stabilization and activity in pancreatic carcinoma cells [33] . In hepatitis B virus-associated hepatocellular carcinoma, an HBx-induced MTA1-HDAC1 complex deacetylates and stabilizes HIF-1α protein [23] . Similarly, MTA1-HDAC1 enhances HIF-1α stability and activity in breast carcinoma cell lines [21] . As MTA2 can deacetylate oestrogen receptor-α and p53, and inhibits their transactivation functions [16, 17] , we hypothesized that MTA2 might regulate the deacetylation and stability of HIF-1α. In agreement with this idea, our results demonstrated that the MTA2-HDAC1 complex induces HIF-1α deacetylation, which leads to increased HIF-1α stability in pancreatic carcinoma cells. Moreover, MTA2 expression was positively correlated with HIF-1α expression in xenograft tumours and pancreatic carcinoma specimens. Therefore, our data identify a reciprocal feedback on HIF-1α and MTA2 that facilitates HIF-1α accumulation in pancreatic carcinoma.
E-cadherin is a major component of adherent junctions, which maintain epithelial integrity and polarity. Loss of E-cadherin is a hallmark of and functional requirement for EMT. Hypoxia induces transcriptional repressors of E-cadherin, including TWIST1, Snail, ZEB1, and ZEB2. These transcription factors bind to the E-box in the E-cadherin promoter, and inhibit E-cadherin expression, which induces EMT in response to hypoxia [34] . As an MTA2-HDAC1 complex is involved in histone deacetylation and transcriptional repression [35] , we wondered whether the MTA2-HDAC1 complex is also associated with hypoxia-induced E-cadherin repression. The present results showed that HIF-1α formed a complex with MTA2 and HDAC1, and recruited them to HREs of the E-cadherin promoter. Inhibition of the MTA2-HDAC1 complex by siRNA impaired the suppressive effect of hypoxia and HIF-1α upregulation on E-cadherin expression, which indicates that the MTA2-HDAC1 complex is necessary for HIF-1α-dependent E-cadherin repression. Moreover, clinical data demonstrated that MTA2 was overexpressed in pancreatic carcinoma, which was correlated with HIF-1α overexpression and E-cadherin downregulation. Therefore, our work verified that the reciprocal loop of MTA2 and HIF-1α reduces E-cadherin levels in pancreatic carcinoma. Similarly, other research has shown that TWIST recruits the MTA2-containing NuRD complex to the E-cadherin promoter for transcriptional repression and promotion of EMT in lung cancer cells [20] . In contrast to other research showing that HIF-1α indirectly represses E-cadherin expression, our data demonstrate that the HIF-1α-MTA2-HDAC1 loop directly inhibits E-cadherin expression by binding to its promoter. Similarly, other research demonstrated Snail and Slug bound the E-boxes in the promoter of E-cadherin and recruited MTA1 and HDAC1 to suppress E-cadherin expression [36] . As MTA1, MTA2 and HDAC1 are components of the NuRD complex, these results imply that NuRD is pivotal for the transcriptional regulation of E-cadherin.
In summary, we demonstrate positive feedback of MTA2 and HIF-1α that promotes hypoxia-induced EMT by repressing E-cadherin. Moreover, MTA2 might be applied as a novel therapeutic target for pancreatic carcinoma. Figure S1 . The expression of MTA2 in pancreatic carcinoma cell lines and normal pancreatic ductal cells Table S1 . The overall survival rate of pancreatic adenocarcinoma patients with different MTA2 mRNA levels 
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